Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes

被引:66
作者
Takahashi, N
Seko, Y
Noiri, E
Tobe, K
Kadowaki, T
Sabe, H
Yazaki, Y
机构
[1] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Bunkyo Ku, Tokyo 1138655, Japan
[3] Asahi Life Fdn, Inst Adult Dis, Shinjuku Ku, Tokyo, Japan
[4] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 113, Japan
[5] Osaka Biosci Inst, Dept Mol Biol, Osaka, Japan
关键词
signal transduction; growth substance; cardiac myocyte; cell adhesion;
D O I
10.1161/01.RES.84.10.1194
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular endothelial growth factor (VEGF) has been proposed to be among the candidate factors with the most potential to play a role in ischemia-induced collateral vessel formation, Recently, we found that VEGF activated the mitogen-activated protein kinase cascade in cultured rat cardiac myocytes, To elucidate how VEGF affects adhesive interaction of cardiac myocytes with the extracellular matrix (ECM), one of the important cell functions, we investigated the molecular mechanism of activation of focal adhesion-related proteins, especially focal adhesion kinase (p125(FAK)), in cultured rat cardiac myocytes, We found that the 2 VEGF receptors, KDR/Flk-1 and Flt-1, were expressed in cardiac myocytes and that KDR/Flk-1 was significantly tyrosine phosphorylated on VEGF stimulation, VEGF induced tyrosine phosphorylation and activation of p125(FAK) as well as tyrosine phosphorylation of paxillin; this was accompanied by subcellular translocation of p125(FAK) from perinuclear sites to the focal adhesions. This VEGF-induced activation of p125(FAK) was inhibited partially by the tyrosine kinase inhibitors genistein and tyrphostin, Activation of p125(FAK) was accompanied by its increased association with adapter proteins GRB2, Shc, and nonreceptor type tyrosine kinase p60(c-src) Furthermore, we confirmed that VEGF induced a significant increase in adhesive interaction between cardiac myocytes and ECM using an electric cell-substrate impedance sensor. These results strongly suggest that p125(FAK) is one of the most important components in VEGF-induced signaling in cardiac myocytes, playing a critical role in adhesive interaction between cardiac myocytes and ECM.
引用
收藏
页码:1194 / 1202
页数:9
相关论文
共 64 条
  • [41] RANKIN S, 1994, J BIOL CHEM, V269, P704
  • [42] ASSOCIATION OF THE SHC AND GRB2/SEM5 SH2-CONTAINING PROTEINS IS IMPLICATED IN ACTIVATION OF THE RAS PATHWAY BY TYROSINE KINASES
    ROZAKISADCOCK, M
    MCGLADE, J
    MBAMALU, G
    PELICCI, G
    DALY, R
    LI, W
    BATZER, A
    THOMAS, S
    BRUGGE, J
    PELICCI, PG
    SCHLESSINGER, J
    PAWSON, T
    [J]. NATURE, 1992, 360 (6405) : 689 - 692
  • [43] The heterotrimeric G(q) protein-coupled angiotensin II receptor activates p21(ras) via the tyrosine kinase-Shc-Grb2-Sos pathway in cardiac myocytes
    Sadoshima, J
    Izumo, S
    [J]. EMBO JOURNAL, 1996, 15 (04) : 775 - 787
  • [44] FOCAL ADHESION KINASE AND PAXILLIN BIND TO PEPTIDES MIMICKING BETA-INTEGRIN CYTOPLASMIC DOMAINS
    SCHALLER, MD
    OTEY, CA
    HILDEBRAND, JD
    PARSONS, JT
    [J]. JOURNAL OF CELL BIOLOGY, 1995, 130 (05) : 1181 - 1187
  • [45] AUTOPHOSPHORYLATION OF THE FOCAL ADHESION KINASE, PP125(FAK), DIRECTS SH2 DEPENDENT BINDING OF PP60(SRC)
    SCHALLER, MD
    HILDEBRAND, JD
    SHANNON, JD
    FOX, JW
    VINES, RR
    PARSONS, JT
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (03) : 1680 - 1688
  • [46] PP125FAK, A STRUCTURALLY DISTINCTIVE PROTEIN-TYROSINE KINASE ASSOCIATED WITH FOCAL ADHESIONS
    SCHALLER, MD
    BORGMAN, CA
    COBB, BS
    VINES, RR
    REYNOLDS, AB
    PARSONS, JT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (11) : 5192 - 5196
  • [47] SCHLAEPFER DD, 1994, NATURE, V372, P786
  • [48] SEETHARAM L, 1995, ONCOGENE, V10, P135
  • [49] Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy
    Seko, Y
    Imai, Y
    Suzuki, S
    Kamijukkoku, S
    Hayasaki, K
    Sakomura, Y
    Tobe, K
    Kadowaki, T
    Maekawa, H
    Takahashi, N
    Yazaki, Y
    [J]. CLINICAL SCIENCE, 1997, 92 (05) : 453 - 454
  • [50] Seko Y, 1998, J CELL PHYSIOL, V175, P239, DOI 10.1002/(SICI)1097-4652(199806)175:3<239::AID-JCP1>3.0.CO